Singapore-headquartered biotech startup Allozymes, which specialises in enzyme discovery and engineering, on Tuesday announced the close of a $15-million Series A round co-led by Seventure Partners and Xora Innovation.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
